Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with

P Nørgaard1, L Damstrup, K Rygaard

  • 1Institute of Pathological Anatomy, University of Copenhagen, Denmark.

Insights

Transforming growth factor beta 1 (TGF-beta 1) suppressed small-cell lung cancer (SCLC) cell growth only in cell lines expressing the type II TGF-beta receptor. Retinoblastoma protein (pRb) was not required for this TGF-beta 1-induced growth suppression in SCLC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Small-cell lung cancer (SCLC) is an aggressive malignancy with limited treatment options.
  • Transforming growth factor beta 1 (TGF-beta 1) is a cytokine with complex roles in cancer, including growth inhibition.
  • The role of TGF-beta 1 signaling and its receptors in SCLC remains incompletely understood.

Purpose of the Study:

  • To investigate the effect of TGF-beta 1 on the growth of human SCLC cell lines.
  • To determine the role of specific TGF-beta receptor (TGF-beta-r) subtypes in mediating TGF-beta 1's effects.
  • To explore the involvement of the retinoblastoma protein (pRb) in TGF-beta 1-induced growth suppression in SCLC.

Main Methods:

  • Treatment of nine human SCLC cell lines with TGF-beta 1.
  • Analysis of TGF-beta-r subtype expression (I, II, III) using various combinations.
  • Assessment of cell growth suppression and morphological changes.
  • Immunocytochemical examination of retinoblastoma protein (pRb) nuclear localization.

Main Results:

  • TGF-beta 1 induced growth suppression exclusively in five cell lines expressing the type II TGF-beta-r.
  • Growth suppression was observed in a cell line expressing only type II TGF-beta-r, without type I coexpression.
  • No growth effects were seen in receptor-negative cell lines or those expressing only type III TGF-beta-r.
  • Nuclear localization of pRb was observed in only two of the five responsive cell lines.

Conclusions:

  • The type II TGF-beta receptor is critical for mediating TGF-beta 1-induced growth suppression in SCLC.
  • TGF-beta 1 can inhibit SCLC cell growth independently of type I TGF-beta receptor coexpression.
  • Functional retinoblastoma protein (pRb) is not essential for TGF-beta 1-mediated growth suppression in SCLC.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...